Review



normal human epidermal keratinocytes  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 99
      Buy from Supplier

    Structured Review

    ATCC normal human epidermal keratinocytes
    Inferred transcriptomic architecture of antioxidant-responsive DEGs. (A) , Number of identified antioxidant-responsive DEGs in each human skin cell type. Bar heights indicate the number of DEGs identified under each treatment condition, with values labeled above each bar. Dark-colored segments represent the subset of AR-DEGs among the antioxidant-responsive DEGs. Bar colors correspond to different treatment conditions. (B) , Regulatory network of DEGs inferred using DoRothEA. Circles represent genes with directed edges from transcription factors to their predicted targets based on the DoRothEA regulon. Nodes are colored by log 2 FC from differential expression analysis in epidermal <t>keratinocytes</t> (above) and melanocytes (below). Gene symbols and log 2 FC values are labeled on each node. Genes with |log 2 FC| ≤ 0.585 are shown with lighter colors and gray text. Aging-related DEGs are marked with an asterisk next to the gene names. (C) , Antioxidative and anti-inflammatory pathways associated with DEGs. Each bar represents a pathway or GO term ( y -axis) identified in this study, with the corresponding −log 10 adjusted P -values from gprofiler2 ( x -axis). The vertical dashed line indicates the significance threshold of adjusted P -value = 0.05. (D) , A selected molecular model illustrates interaction between treatment of CGA and taurine and genes related with anti-aging mechanisms. Abbreviations: CGA, chlorogenic acid; CGA + Tau, combined treatment of chlorogenic acid and taurine; log 2 FC, Bayesian shrinkage estimator for log 2 fold change.
    Normal Human Epidermal Keratinocytes, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 381 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/normal human epidermal keratinocytes/product/ATCC
    Average 99 stars, based on 381 article reviews
    normal human epidermal keratinocytes - by Bioz Stars, 2026-05
    99/100 stars

    Images

    1) Product Images from "Transcriptomic profiling of chlorogenic acid and taurine treatment in human skin cells provides insights into cellular senescence mechanisms"

    Article Title: Transcriptomic profiling of chlorogenic acid and taurine treatment in human skin cells provides insights into cellular senescence mechanisms

    Journal: Frontiers in Molecular Biosciences

    doi: 10.3389/fmolb.2026.1748185

    Inferred transcriptomic architecture of antioxidant-responsive DEGs. (A) , Number of identified antioxidant-responsive DEGs in each human skin cell type. Bar heights indicate the number of DEGs identified under each treatment condition, with values labeled above each bar. Dark-colored segments represent the subset of AR-DEGs among the antioxidant-responsive DEGs. Bar colors correspond to different treatment conditions. (B) , Regulatory network of DEGs inferred using DoRothEA. Circles represent genes with directed edges from transcription factors to their predicted targets based on the DoRothEA regulon. Nodes are colored by log 2 FC from differential expression analysis in epidermal keratinocytes (above) and melanocytes (below). Gene symbols and log 2 FC values are labeled on each node. Genes with |log 2 FC| ≤ 0.585 are shown with lighter colors and gray text. Aging-related DEGs are marked with an asterisk next to the gene names. (C) , Antioxidative and anti-inflammatory pathways associated with DEGs. Each bar represents a pathway or GO term ( y -axis) identified in this study, with the corresponding −log 10 adjusted P -values from gprofiler2 ( x -axis). The vertical dashed line indicates the significance threshold of adjusted P -value = 0.05. (D) , A selected molecular model illustrates interaction between treatment of CGA and taurine and genes related with anti-aging mechanisms. Abbreviations: CGA, chlorogenic acid; CGA + Tau, combined treatment of chlorogenic acid and taurine; log 2 FC, Bayesian shrinkage estimator for log 2 fold change.
    Figure Legend Snippet: Inferred transcriptomic architecture of antioxidant-responsive DEGs. (A) , Number of identified antioxidant-responsive DEGs in each human skin cell type. Bar heights indicate the number of DEGs identified under each treatment condition, with values labeled above each bar. Dark-colored segments represent the subset of AR-DEGs among the antioxidant-responsive DEGs. Bar colors correspond to different treatment conditions. (B) , Regulatory network of DEGs inferred using DoRothEA. Circles represent genes with directed edges from transcription factors to their predicted targets based on the DoRothEA regulon. Nodes are colored by log 2 FC from differential expression analysis in epidermal keratinocytes (above) and melanocytes (below). Gene symbols and log 2 FC values are labeled on each node. Genes with |log 2 FC| ≤ 0.585 are shown with lighter colors and gray text. Aging-related DEGs are marked with an asterisk next to the gene names. (C) , Antioxidative and anti-inflammatory pathways associated with DEGs. Each bar represents a pathway or GO term ( y -axis) identified in this study, with the corresponding −log 10 adjusted P -values from gprofiler2 ( x -axis). The vertical dashed line indicates the significance threshold of adjusted P -value = 0.05. (D) , A selected molecular model illustrates interaction between treatment of CGA and taurine and genes related with anti-aging mechanisms. Abbreviations: CGA, chlorogenic acid; CGA + Tau, combined treatment of chlorogenic acid and taurine; log 2 FC, Bayesian shrinkage estimator for log 2 fold change.

    Techniques Used: Labeling, Quantitative Proteomics



    Similar Products

    normal human epidermal keratinocytes  (ATCC)
    99
    ATCC normal human epidermal keratinocytes
    Inferred transcriptomic architecture of antioxidant-responsive DEGs. (A) , Number of identified antioxidant-responsive DEGs in each human skin cell type. Bar heights indicate the number of DEGs identified under each treatment condition, with values labeled above each bar. Dark-colored segments represent the subset of AR-DEGs among the antioxidant-responsive DEGs. Bar colors correspond to different treatment conditions. (B) , Regulatory network of DEGs inferred using DoRothEA. Circles represent genes with directed edges from transcription factors to their predicted targets based on the DoRothEA regulon. Nodes are colored by log 2 FC from differential expression analysis in epidermal <t>keratinocytes</t> (above) and melanocytes (below). Gene symbols and log 2 FC values are labeled on each node. Genes with |log 2 FC| ≤ 0.585 are shown with lighter colors and gray text. Aging-related DEGs are marked with an asterisk next to the gene names. (C) , Antioxidative and anti-inflammatory pathways associated with DEGs. Each bar represents a pathway or GO term ( y -axis) identified in this study, with the corresponding −log 10 adjusted P -values from gprofiler2 ( x -axis). The vertical dashed line indicates the significance threshold of adjusted P -value = 0.05. (D) , A selected molecular model illustrates interaction between treatment of CGA and taurine and genes related with anti-aging mechanisms. Abbreviations: CGA, chlorogenic acid; CGA + Tau, combined treatment of chlorogenic acid and taurine; log 2 FC, Bayesian shrinkage estimator for log 2 fold change.
    Normal Human Epidermal Keratinocytes, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/normal human epidermal keratinocytes/product/ATCC
    Average 99 stars, based on 1 article reviews
    normal human epidermal keratinocytes - by Bioz Stars, 2026-05
    99/100 stars
    		  Buy from Supplier
    primary epidermal keratinocytes; normal, human, neonatal foreskin  (ATCC)
    99
    ATCC primary epidermal keratinocytes; normal, human, neonatal foreskin
    Inferred transcriptomic architecture of antioxidant-responsive DEGs. (A) , Number of identified antioxidant-responsive DEGs in each human skin cell type. Bar heights indicate the number of DEGs identified under each treatment condition, with values labeled above each bar. Dark-colored segments represent the subset of AR-DEGs among the antioxidant-responsive DEGs. Bar colors correspond to different treatment conditions. (B) , Regulatory network of DEGs inferred using DoRothEA. Circles represent genes with directed edges from transcription factors to their predicted targets based on the DoRothEA regulon. Nodes are colored by log 2 FC from differential expression analysis in epidermal <t>keratinocytes</t> (above) and melanocytes (below). Gene symbols and log 2 FC values are labeled on each node. Genes with |log 2 FC| ≤ 0.585 are shown with lighter colors and gray text. Aging-related DEGs are marked with an asterisk next to the gene names. (C) , Antioxidative and anti-inflammatory pathways associated with DEGs. Each bar represents a pathway or GO term ( y -axis) identified in this study, with the corresponding −log 10 adjusted P -values from gprofiler2 ( x -axis). The vertical dashed line indicates the significance threshold of adjusted P -value = 0.05. (D) , A selected molecular model illustrates interaction between treatment of CGA and taurine and genes related with anti-aging mechanisms. Abbreviations: CGA, chlorogenic acid; CGA + Tau, combined treatment of chlorogenic acid and taurine; log 2 FC, Bayesian shrinkage estimator for log 2 fold change.
    Primary Epidermal Keratinocytes; Normal, Human, Neonatal Foreskin, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary epidermal keratinocytes; normal, human, neonatal foreskin/product/ATCC
    Average 99 stars, based on 1 article reviews
    primary epidermal keratinocytes; normal, human, neonatal foreskin - by Bioz Stars, 2026-05
    99/100 stars
    		  Buy from Supplier
    human epidermal keratinocytes neonatal  (ATCC)
    99
    ATCC human epidermal keratinocytes neonatal
    Inferred transcriptomic architecture of antioxidant-responsive DEGs. (A) , Number of identified antioxidant-responsive DEGs in each human skin cell type. Bar heights indicate the number of DEGs identified under each treatment condition, with values labeled above each bar. Dark-colored segments represent the subset of AR-DEGs among the antioxidant-responsive DEGs. Bar colors correspond to different treatment conditions. (B) , Regulatory network of DEGs inferred using DoRothEA. Circles represent genes with directed edges from transcription factors to their predicted targets based on the DoRothEA regulon. Nodes are colored by log 2 FC from differential expression analysis in epidermal <t>keratinocytes</t> (above) and melanocytes (below). Gene symbols and log 2 FC values are labeled on each node. Genes with |log 2 FC| ≤ 0.585 are shown with lighter colors and gray text. Aging-related DEGs are marked with an asterisk next to the gene names. (C) , Antioxidative and anti-inflammatory pathways associated with DEGs. Each bar represents a pathway or GO term ( y -axis) identified in this study, with the corresponding −log 10 adjusted P -values from gprofiler2 ( x -axis). The vertical dashed line indicates the significance threshold of adjusted P -value = 0.05. (D) , A selected molecular model illustrates interaction between treatment of CGA and taurine and genes related with anti-aging mechanisms. Abbreviations: CGA, chlorogenic acid; CGA + Tau, combined treatment of chlorogenic acid and taurine; log 2 FC, Bayesian shrinkage estimator for log 2 fold change.
    Human Epidermal Keratinocytes Neonatal, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human epidermal keratinocytes neonatal/product/ATCC
    Average 99 stars, based on 1 article reviews
    human epidermal keratinocytes neonatal - by Bioz Stars, 2026-05
    99/100 stars
    		  Buy from Supplier
    nheks  (ATCC)
    99
    ATCC nheks
    Inferred transcriptomic architecture of antioxidant-responsive DEGs. (A) , Number of identified antioxidant-responsive DEGs in each human skin cell type. Bar heights indicate the number of DEGs identified under each treatment condition, with values labeled above each bar. Dark-colored segments represent the subset of AR-DEGs among the antioxidant-responsive DEGs. Bar colors correspond to different treatment conditions. (B) , Regulatory network of DEGs inferred using DoRothEA. Circles represent genes with directed edges from transcription factors to their predicted targets based on the DoRothEA regulon. Nodes are colored by log 2 FC from differential expression analysis in epidermal <t>keratinocytes</t> (above) and melanocytes (below). Gene symbols and log 2 FC values are labeled on each node. Genes with |log 2 FC| ≤ 0.585 are shown with lighter colors and gray text. Aging-related DEGs are marked with an asterisk next to the gene names. (C) , Antioxidative and anti-inflammatory pathways associated with DEGs. Each bar represents a pathway or GO term ( y -axis) identified in this study, with the corresponding −log 10 adjusted P -values from gprofiler2 ( x -axis). The vertical dashed line indicates the significance threshold of adjusted P -value = 0.05. (D) , A selected molecular model illustrates interaction between treatment of CGA and taurine and genes related with anti-aging mechanisms. Abbreviations: CGA, chlorogenic acid; CGA + Tau, combined treatment of chlorogenic acid and taurine; log 2 FC, Bayesian shrinkage estimator for log 2 fold change.
    Nheks, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nheks/product/ATCC
    Average 99 stars, based on 1 article reviews
    nheks - by Bioz Stars, 2026-05
    99/100 stars
    		  Buy from Supplier
    hok  (ATCC)
    99
    ATCC hok
    Inferred transcriptomic architecture of antioxidant-responsive DEGs. (A) , Number of identified antioxidant-responsive DEGs in each human skin cell type. Bar heights indicate the number of DEGs identified under each treatment condition, with values labeled above each bar. Dark-colored segments represent the subset of AR-DEGs among the antioxidant-responsive DEGs. Bar colors correspond to different treatment conditions. (B) , Regulatory network of DEGs inferred using DoRothEA. Circles represent genes with directed edges from transcription factors to their predicted targets based on the DoRothEA regulon. Nodes are colored by log 2 FC from differential expression analysis in epidermal <t>keratinocytes</t> (above) and melanocytes (below). Gene symbols and log 2 FC values are labeled on each node. Genes with |log 2 FC| ≤ 0.585 are shown with lighter colors and gray text. Aging-related DEGs are marked with an asterisk next to the gene names. (C) , Antioxidative and anti-inflammatory pathways associated with DEGs. Each bar represents a pathway or GO term ( y -axis) identified in this study, with the corresponding −log 10 adjusted P -values from gprofiler2 ( x -axis). The vertical dashed line indicates the significance threshold of adjusted P -value = 0.05. (D) , A selected molecular model illustrates interaction between treatment of CGA and taurine and genes related with anti-aging mechanisms. Abbreviations: CGA, chlorogenic acid; CGA + Tau, combined treatment of chlorogenic acid and taurine; log 2 FC, Bayesian shrinkage estimator for log 2 fold change.
    Hok, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/hok/product/ATCC
    Average 99 stars, based on 1 article reviews
    hok - by Bioz Stars, 2026-05
    99/100 stars
    		  Buy from Supplier

    Image Search Results


    Inferred transcriptomic architecture of antioxidant-responsive DEGs. (A) , Number of identified antioxidant-responsive DEGs in each human skin cell type. Bar heights indicate the number of DEGs identified under each treatment condition, with values labeled above each bar. Dark-colored segments represent the subset of AR-DEGs among the antioxidant-responsive DEGs. Bar colors correspond to different treatment conditions. (B) , Regulatory network of DEGs inferred using DoRothEA. Circles represent genes with directed edges from transcription factors to their predicted targets based on the DoRothEA regulon. Nodes are colored by log 2 FC from differential expression analysis in epidermal keratinocytes (above) and melanocytes (below). Gene symbols and log 2 FC values are labeled on each node. Genes with |log 2 FC| ≤ 0.585 are shown with lighter colors and gray text. Aging-related DEGs are marked with an asterisk next to the gene names. (C) , Antioxidative and anti-inflammatory pathways associated with DEGs. Each bar represents a pathway or GO term ( y -axis) identified in this study, with the corresponding −log 10 adjusted P -values from gprofiler2 ( x -axis). The vertical dashed line indicates the significance threshold of adjusted P -value = 0.05. (D) , A selected molecular model illustrates interaction between treatment of CGA and taurine and genes related with anti-aging mechanisms. Abbreviations: CGA, chlorogenic acid; CGA + Tau, combined treatment of chlorogenic acid and taurine; log 2 FC, Bayesian shrinkage estimator for log 2 fold change.

    Journal: Frontiers in Molecular Biosciences

    Article Title: Transcriptomic profiling of chlorogenic acid and taurine treatment in human skin cells provides insights into cellular senescence mechanisms

    doi: 10.3389/fmolb.2026.1748185

    Figure Lengend Snippet: Inferred transcriptomic architecture of antioxidant-responsive DEGs. (A) , Number of identified antioxidant-responsive DEGs in each human skin cell type. Bar heights indicate the number of DEGs identified under each treatment condition, with values labeled above each bar. Dark-colored segments represent the subset of AR-DEGs among the antioxidant-responsive DEGs. Bar colors correspond to different treatment conditions. (B) , Regulatory network of DEGs inferred using DoRothEA. Circles represent genes with directed edges from transcription factors to their predicted targets based on the DoRothEA regulon. Nodes are colored by log 2 FC from differential expression analysis in epidermal keratinocytes (above) and melanocytes (below). Gene symbols and log 2 FC values are labeled on each node. Genes with |log 2 FC| ≤ 0.585 are shown with lighter colors and gray text. Aging-related DEGs are marked with an asterisk next to the gene names. (C) , Antioxidative and anti-inflammatory pathways associated with DEGs. Each bar represents a pathway or GO term ( y -axis) identified in this study, with the corresponding −log 10 adjusted P -values from gprofiler2 ( x -axis). The vertical dashed line indicates the significance threshold of adjusted P -value = 0.05. (D) , A selected molecular model illustrates interaction between treatment of CGA and taurine and genes related with anti-aging mechanisms. Abbreviations: CGA, chlorogenic acid; CGA + Tau, combined treatment of chlorogenic acid and taurine; log 2 FC, Bayesian shrinkage estimator for log 2 fold change.

    Article Snippet: Normal Human Epidermal Keratinocytes (Cat. no. PCS-200–010; ATCC, Manassas, VA, United States) were cultured in Keratinocyte Growth Medium (Lonza, KGMTM Gold, Cat. no. 00192060; BS, Switzerland) supplemented with 10% fetal bovine serum (Gibco, Waltham, MA, United States), 100 U/mL penicillin, and 100 μg/mL streptomycin (Gibco).

    Techniques: Labeling, Quantitative Proteomics